All women of Ashkenazi descent should be screened from age 30 for the BRCA gene mutation that causes breast cancer, an Israeli study recommends.
The study, by a research team headed by Professor Ephrat Levy-Lahad of Shaare Zedek Medical Center, was published Friday in the journal Proceedings of the National Academy of Sciences of the United States of America.
Up until now, Ashkenazi women have been tested for the BRCA1 and BRCA2 genes only if a close blood relative developed breast or ovarian cancer or was identified as carrying the gene.
The research was conducted on a random group of Jewish women of Ashkenazi origin, who did not necessarily have a family history of the disease.
Many of the women identified during the study as being mutation carriers would not have known otherwise, according to the study. The mutation can be handed down to women through their fathers.
The Times of Israel covers one of the most complicated, and contentious, parts of the world. Determined to keep readers fully informed and enable them to form and flesh out their own opinions, The Times of Israel has gradually established itself as the leading source of independent and fair-minded journalism on Israel, the region and the Jewish world.
We've achieved this by investing ever-greater resources in our journalism while keeping all of the content on our site free.
Unlike many other news sites, we have not put up a paywall. But we would like to invite readers who can afford to do so, and for whom The Times of Israel has become important, to help support our journalism by joining The Times of Israel Community. Join now and for as little as $6 a month you can both help ensure our ongoing investment in quality journalism, and enjoy special status and benefits as a Times of Israel Community member.